Numerous people across the United Kingdom are experiencing a puzzling and severe skin disorder that has stumped doctors. Sufferers report their skin becoming severely inflamed, cracked and peeling, often across their entire bodies, yet many doctors struggle to diagnose or treat the condition. The occurrence, called topical steroid withdrawal (TSW) or red skin syndrome, has sparked unprecedented interest on online platforms, with clips featuring patients’ experiences garnering over a billion views on TikTok alone. Despite affecting a rising number of people, TSW remains so inadequately understood that some doctors and dermatologists query whether it actually exists at all. Now, for the very first time, researchers across the UK are commencing a significant research project to investigate what is behind these mysterious symptoms and how some people come to develop the condition whilst others do not.
The Mysterious Illness Spreading Across the UK
Bethany Gamble’s experience exemplifies the severe consequences of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had handled her eczema well with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became intensely inflamed and red, breaking and leaking whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so acute that she was unable to leave her bed, dependent on continuous support from her mother. Most concerning, Bethany found herself repeatedly dismissed by doctors who attributed her symptoms to standard eczema and kept prescribing the very treatments she suspected were triggering her suffering.
The healthcare sector remains divided on how to address TSW, with deep divisions about its very nature. Some experts consider it a severe allergic response to the steroid-based creams that serve as the primary treatment for eczema across the NHS. Others contend it amounts to a severe flare-up of current skin conditions rather than a unique syndrome, whilst a minority remain unconvinced of its existence. This professional uncertainty has left patients like Bethany trapped in a state of diagnostic limbo, struggling to access proper treatment. The lack of consensus has prompted Professor Sara Brown at the Edinburgh University to establish the first significant UK research initiative investigating TSW, supported by the National Eczema Society.
- Symptoms include significant swelling, skin fissuring and persistent pruritus throughout the body
- Patients report “elephant skin” thickening and extreme shedding of keratinised cells
- Medical professionals often dismiss TSW as typical dermatitis or refuse to acknowledge it
- The condition may prove so incapacitating that sufferers find themselves unable to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Manageable Eczema to Disabling Symptoms
For numerous sufferers, topical steroid withdrawal represents a catastrophic deterioration from a previously stable dermatological condition. What starts with intermittent itching in areas of skin fold can quickly progress into a full-body inflammatory response that renders patients incapable of functioning. The transition often occurs suddenly, without warning, converting a controllable long-term condition into an severe medical emergency. People describe their skin turning intensely hot, red and inflamed, with significant cracking and weeping that requires constant attention. The physical toll is worsened by fatigue, as the persistent itching disrupts sleep and healing, establishing a vicious cycle of deterioration.
The rate at which TSW progresses takes many sufferers by surprise. Those who have experienced eczema for years, sometimes decades, are unprepared for the severity of symptoms that appear when their condition rapidly deteriorates. Routine activities become formidable obstacles: showering becomes unbearable, dressing needs support, and maintaining personal hygiene demands enormous effort. Some patients report feeling as though their skin is being ravaged from within, with inflammation moving through their body in patterns that show little similarity to their previous eczema flare-ups. This dramatic transformation often drives sufferers to obtain emergency care, only to face doubt from healthcare professionals.
The Fight for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the dismissive medical responses that frequently accompanies it. Patients experiencing serious, unexplained health issues are consistently informed they simply have eczema worsening, despite their assertion that this is fundamentally different from anything they’ve experienced before. Doctors often respond by recommending higher-strength steroids or higher dosages, potentially worsening the very condition patients suspect the topical treatments triggered. This cycle of dismissal leaves sufferers feeling abandoned by the medical establishment, forced to navigate their illness alone whilst being informed that their personal experience lacks validity. Many patients report experiencing repeated invalidation, their worries disregarded as anxiety or psychological rather than actual physical health issues.
The absence of medical consensus has established a significant divide between patient experience and professional recognition. Without clear diagnostic criteria or defined treatment approaches, GPs and dermatologists find it difficult to diagnose TSW or offer appropriate support. Some clinicians remain entirely unconvinced the condition exists, viewing all severe presentations as standard eczema or other known dermatological conditions. This professional uncertainty results in delayed diagnosis, inappropriate treatment and significant emotional suffering for people experiencing physical symptoms. The growing visibility of TSW on online platforms has drawn attention to this diagnostic void, prompting researchers to examine the experiences reported by vast numbers of individuals, even as the healthcare profession remains divided on how to respond.
- Signs may develop suddenly in individuals with formerly controlled eczema managed by topical steroids
- Patients often face disbelief from medical practitioners who ascribe worsening to typical eczema exacerbations
- Medical professionals continue to disagree on whether TSW is a real disorder or severe eczema exacerbation
- Absence of established diagnostic standards means many sufferers struggle to access suitable care and support
- Social media has magnified voices of patients, with TSW hashtags reaching more than one billion views globally
Ethnic Inequalities in Diagnostic and Treatment Pathways
The diagnostic difficulties surrounding topical steroid withdrawal become more acute amongst those with darker complexions, where symptoms can be considerably more difficult to recognise visually. Redness and inflammation, the characteristic indicators of TSW in people with lighter skin, present distinctly across multiple populations, yet many diagnostic frameworks remain centred on how the condition appears in white patients. This gap means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW often face even greater delays in recognition and validation. Healthcare professionals trained mainly through presentations in lighter skin may fail to recognise the characteristic signs, leading to continued misidentification and inappropriate treatment recommendations that can intensify distress.
Research into TSW has historically overlooked the experiences of people with darker complexions, perpetuating a cycle where their symptoms remain under-documented and under-studied. The online discussions shaping TSW discourse have been largely shaped by individuals with lighter complexions, risking distortion of medical understanding and community understanding. As Professor Sara Brown’s pioneering British research progresses, ensuring diverse representation amongst participants will be essential to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without deliberate efforts to prioritise the perspectives of all ethnic groups, treatment inequalities in TSW identification and care risk widening further, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Options Coming to Light
Leading UK Research Project Currently Happening
Professor Sara Brown’s pioneering research at the University of Edinburgh represents a watershed moment for TSW sufferers pursuing validation and comprehension. Funded by the National Eczema Society, the study has brought together hundreds of participants across the UK to examine the physiological processes driving topical steroid withdrawal. By analysing symptoms, saliva samples and skin biopsies, researchers hope to identify why some people exhibit TSW whilst others using identical steroid regimens do not. This detailed analysis marks a notable change from dismissal to serious investigation.
The investigative group partnering with Dr Alice Burleigh from patient advocacy group Scratch That, brings both clinical knowledge and firsthand experience to the investigation. Their partnership approach accepts that patients themselves hold crucial insights into their medical conditions. Professor Brown has identified patterns in TSW that defy explanation by traditional understanding of eczema, including marked “elephant skin” thickening, extreme shedding and clearly defined areas of inflammation. The research findings could significantly transform how healthcare practitioners manage diagnosis and treatment of this serious condition.
Available Treatments and Associated Limitations
Currently, therapeutic approaches to TSW remain limited and frequently inadequate. Many clinicians continue prescribing topical steroids despite evidence suggesting they may exacerbate symptoms in those predisposed. Some patients report temporary relief from emollients, antihistamines and oral medications, though results vary widely. Dermatologists continue to disagree on optimal management strategies, with some supporting total steroid discontinuation whilst others suggest slow reduction. This lack of consensus forces patients to navigate their therapeutic pathways largely alone, drawing substantially on peer support networks and web-based forums for direction.
Psychological assistance with specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including changes to diet, environmental controls and whole-person treatment approaches, though scientific evidence supporting these interventions remains sparse. The absence of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than research-informed standards. Until robust research produces definitive answers, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollients and moisturisers to support skin barrier function and minimise water loss
- Antihistamine medications to alleviate itching and associated sleep disruption in flare episodes
- Systemic corticosteroids or immunosuppressants for severe cases under specialist supervision
- Psychological counselling to tackle emotional distress and worry stemming from prolonged skin suffering
Expressions of Hope and Commitment
Despite the uncertainty surrounding TSW and the often dismissive attitudes from medical practitioners, patients are drawing strength in shared community and shared experience. Digital support communities have proven vital for those struggling with the disorder, providing practical guidance and validation when conventional medicine has let them down. Many individuals affected describe the moment they discovered the TSW hashtag as pivotal—finally connecting with others with the same symptoms and realising they were not alone in their experience. This unified voice has been powerful enough to trigger the first serious research efforts, demonstrating that patient-led campaigns can drive medical progress even when institutional structures stay unconvinced.
Bethany Gamble and people in similar situations are determined to draw attention and push for appropriate acknowledgement of TSW within the medical community. Their readiness to share deeply personal accounts of their challenges on online platforms has encouraged open dialogue around a illness that many doctors still refuse to acknowledge. These individuals are not remaining passive for responses; they are taking part in research studies, tracking their signs thoroughly, and demanding that their experiences be given proper consideration. Their resilience in the midst of persistent distress and invalidating medical treatment suggests possibility that answers may finally be within attainment, and that future patients will be given the acknowledgement and treatment they urgently require.
- Patient-led research initiatives are addressing shortcomings overlooked by conventional healthcare systems and accelerating understanding of TSW
- Online communities offer psychological assistance, actionable management techniques, and mutual recognition for isolated sufferers globally
- Campaign work are gradually shifting clinical attitudes, encouraging dermatologists to examine rather than dismiss individual accounts
